Antiparkinson Drugs Flashcards

0
Q

akinesia

A

classically defined as “without movement;” absence or poverty of movement that results in a mask like facial expression and impaired postural reflexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

adjunctive drugs

A

drugs that are added as a second drug for combined therapy with a primary drug and may have addictive or independent properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

bradykinesia

A

slowness of movement; a classic symptom of Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

chorea

A

a condition characterised by involuntary, purposeless, rapid motions (e.g. flexing and extending the fingers, raising and lowering the shoulders, or grimacing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dyskinesia

A

term for abnormal and distressing involuntary movements; inability to control movements, which often occurs as a side effect of levodopa therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dystonia

A

impaired or distorted voluntary movement, often involving the head, neck, or feet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

exogenous

A

a term describing any substance produced outside of the body that may be taken into the body (e.g. a medication, food, or environmental toxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

on-off phenomenon

A

a common experience of patients taking medication for Parkinson’s disease in which they experience periods of greater symptomatic control (“on” time) alternating with periods of lesser symptomatic control (“off” time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Parkinson’s disease

A

a slowly progressive, degenerative neurologic disorder characterised by resting tremor, pill-rolling of the fingers, masklike facies, shuffling gait, forward flexion of the trunk, loss of postural reflexes, and muscle rigidity and weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

postural instability

A

a decrease or change in motor and muscle movements that leads to unsteadiness and hesitation in movement and gait when the individual starts or stops walking, or causes leaning to the left or right when sitting; occurs in Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

presynaptic

A

drugs that exert their antiparkinson effects before the nerve synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

rigidity

A

resistance of the muscles to passive movement; leads to the “cogwheel” rigidity seen in Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TRAP

A

(tremor, rigidity, akinesia, postural instability); an acronym for symptoms of Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

tremor

A

In Parkinson’s disease, shakiness of the extremities seen mostly at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

wearing-off phenomenon

A

a gradual worsening of parkinsonian symptoms as a patient’s medications begin to lose their effectiveness, despite maximal dosing with a variety of medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

adverse effects of antiparkinson drugs: MAO-B inhibitor (e.g. selegine)

A

dizziness, insomnia, hallucinations, ataxia, agitation, depression, paresthesia, somnolence, headache, dyskinesia, nausea, diarrhoea, hypotension or hypertension, chest pain, weight loss, dermatologic reactions, rhinitis, pharyngitis

16
Q

adverse effects of antiparkinson drugs: dopamine modulator (e.g. amantadine)

A

dizziness, insomnia, agitation, anxiety, headache, hallucinations, nausea, orthostatic hypotension, peripheral oedema, dry mouth

17
Q

adverse effects of antiparkinson drugs: COMT inhibitors (e.g. entacapone, tolcapone)

A

GI upset, dyskinesia, urine discolouration, orthostatic hypotension, syncope, dizziness, fatigue, hallucinations, anxiety, somnolence, rash, dyspnea, worsening of dyskinesia

tolcapone: liver failure

18
Q

adverse effects of antiparkinson drugs: anticholinergic agent (e.g. benztropine)

A

tachycardia; confusion; memory impairment; rash; hyperthermia; constipation; dry throat, nose, or mouth; nausea; vomiting; urinary retention; blurred vision; fever

19
Q

adverse effects of antiparkinson drugs: ergot derivative (e.g. bromocriptine)

A

ataxia, dizziness, headache, depression, drowsiness, GI upset, visual changes

20
Q

adverse effects of antiparkinson drugs: nonergot derivative (e.g. pramipexole, ropinirole)

A

oedema, fatigue, syncope, dizziness, drowsiness, GI upset

21
Q

adverse effects of antiparkinson drugs: dopamine replacement drugs (e.g. levodopa, carbidopa-levidopa combination)

A

palpitations, hypotension, urinary retention, depression, dyskinesia

22
Q

antiparkinson drugs

A

amantadine, benztropine mesylate, bromocriptine, carbidopa-levodopa, entacapone, ropinirole, selegiline and rasagiline